FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce ...
FDA approves Alhemo®, a subcutaneous injection for hemophilia A or B with inhibitors, reducing bleeds by 86% in prophylaxis users.
Highlighted Terms
Related News
FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce ...
FDA approves Alhemo®, a subcutaneous injection for hemophilia A or B with inhibitors, reducing bleeds by 86% in prophylaxis users.